Jane Street’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$404K Buy
+12,613
New +$350K ﹤0.01% 8519
2023
Q3
– Sell
-1,909
Closed -$55.1K – 8747
2023
Q2
$55.1K Buy
+1,909
New +$69.2K ﹤0.01% 8188
2023
Q1
– Sell
-182
Closed -$16.7K – 9171
2022
Q4
$16.7K Buy
+182
New +$15.1K ﹤0.01% 8647
2022
Q3
– Sell
-416
Closed -$32K – 9812
2022
Q2
$32K Buy
+416
New +$41.7K ﹤0.01% 9038
2021
Q4
– Sell
-119
Closed -$51K – 10167
2021
Q3
$51K Buy
+119
New +$54.5K ﹤0.01% 9540

Other funds holding KRSA

Jane Street's KRSA Position: Q3 2026 in Review

Jane Street opened a new position in Korsana Biosciences (KRSA) in Q3 2026: 12,613 shares worth $404K. The stake represents ﹤0.01% of the portfolio and ranks #8519 among its holdings. This is a return to the name: Jane Street previously reported a position in KRSA as recently as Q2 2023.

Jane Street first reported a position in KRSA in Q3 2021 and has held it in 5 quarters since. 44 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

  • Jane Street held 12,613 shares of Korsana Biosciences worth $404K as of Q3 2026.
  • Korsana Biosciences was a new Jane Street position in Q3 2026.
  • Korsana Biosciences made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8519 holding.
  • Jane Street first reported a position in Korsana Biosciences in Q3 2021 and has held it in 5 quarters since.
  • 44 funds tracked by Wall St. Rank held Korsana Biosciences as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.